R&D

Apart from providing quality and affordable generic drugs to the global healthcare system, focus on R&D is a key value driver at Orchid. We recognise the importance of developing knowledge-intensive businesses as drivers of future growth. Orchid is a partner of choice to select global pharma companies in the areas of new chemical entity (NCE) development, novel drug delivery systems (NDDS) development, custom synthesis and R&D services. Our R&D Centres located in Chennai are GLP (Good Laboratory Practice) certified and equipped with sophisticated analytical and chemical laboratory equipment, supported by a good technical infrastructure for discovering and developing new drugs.

Our scientific personnel comprise of over 600 scientists across the entire spectrum of R&D and analytical research, working in various areas of drug discovery and development in addition to CMC (chemistry, manufacturing and controls), pharma research and other related processes and pharma research activities. Our people strive to create clinically differentiated drugs and diagnostics to help people live longer and healthier. To drive a stronger focus in the discovery and development area, we have developed a proprietary product pipeline and collaborated with multinational companies for discovery of new chemical entities to undertake co-discovery and/or co-development projects, as well as provide custom research services.